- Drug Name: Brenzavvy
- Generic Name: Bexagliflozin
- Dosage Forms and Strengths: Tablets: 20mg
- Manufactured by: TheracosBio
BRENZAVVY is a medication that falls into the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. It is recommended as an addition to dietary and exercise measures to enhance the management of blood sugar levels in adults diagnosed with type 2 diabetes. Limitation of Use: This medication is not advisable for patients with type 1 diabetes. Its use in such cases may heighten the risk of a condition called diabetic ketoacidosis.
Dosage And Administration:
- The suggested dose is 20 mg once daily, to be taken in the morning, with or without food. It’s essential not to crush or chew the tablet.
- Before starting BRENZAVVY, it is necessary to evaluate the patient’s kidney function and make corrections as needed.
- This medication should not be used if the estimated glomerular filtration rate (eGFR) is less than 30 mL/min/1.73 m².
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.